Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Letters

Neural tube defects

Heather Dean, Kelly Watson and Elizabeth A.C. Sellers
CMAJ January 18, 2005 172 (2) 158-159; DOI: https://doi.org/10.1503/cmaj.1041602
Heather Dean
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Watson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A.C. Sellers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2005 Canadian Medical Association or its licensors

Joel Ray and associates1 found that in Ontario the risk of neural tube defects was higher among First Nations women than among women of other ethnic origins, independent of age, body weight and pregestational diabetes. The prevalence of type 2 diabetes among First Nations adolescents in Manitoba and northwestern Ontario is increasing, and the poor diabetes control and poor nutrition that often occur in these young women may constitute additional risk factors for neural tube defects in future offspring.

The high rate of adolescent pregnancy and the additional risk of neural tube defects in First Nations women raise the question of whether all young First Nations women with type 2 diabetes should receive advice regarding dietary and supplemental folic acid.

Several recent clinical practice guidelines have included recommendations on folic acid supplementation for mothers at high risk for neural tube defects. In 2003 the Society of Obstetricians and Gynaecologists of Canada recommended that all “women with insulin-dependent diabetes” should be advised to take high-dose folic acid (4–5 mg, taken as a pure folic acid supplement).2 In 2002 Health Canada recommended that “women with diabetes” reduce the risk of neural tube defects in their babies by ensuring optimal diabetes control in the periconceptional period, noting that high-dose folic acid may or may not provide added benefit.3 The 2003 guidelines of the Canadian Diabetes Association reviewed the evidence for reduction of the risk of neural tube defects with folic acid supplementation in diabetic pregnancies but stopped short of any specific recommendation regarding folic acid.4 A 1997 recommendation by the Canadian Paediatric Society made no special recommendation for women with diabetes,5 but this position statement is currently under revision.

Young First Nations women with type 2 diabetes may have multiple factors putting their future offspring at high risk for neural tube defects, namely ethnicity, poor diabetes control and poor nutrition. The evidence for risk reduction with optimal preconception control of diabetes in young women with type 1 diabetes3 is probably applicable to young First Nations women with type 2 diabetes. However, the other unique clinical features of this population necessitate the development of specific consensus guidelines for folic acid supplementation for prevention of neural tube defects.

References

  1. 1.↵
    Ray JG, Vermeulen MJ, Meier C, Cole DEC, Wyatt PR. Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ 2004; 171(4):343-5.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Wilson DR. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2003;138:1-7.
    OpenUrl
  3. 3.↵
    Van Allen MI, McCourt C, Lee NS. Preconception health — folic acid for the primary prevention of neural tube defects. A resource document for health professionals, 2002. Ottawa: Health Canada; 2002. Cat no. H39-607/2002E 2). Available: www.hc-sc.gc.ca/english/folicacid/report/full_report.html (accessed 2004 Nov 16).
  4. 4.↵
    Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003; 27(Suppl 2):S94.
  5. 5.↵
    Periconceptional use of folic acid for reduction of the risk of neural tube defects. Pediatr Child Health 1997;2:152-4.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 172 (2)
CMAJ
Vol. 172, Issue 2
18 Jan 2005
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neural tube defects
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Neural tube defects
Heather Dean, Kelly Watson, Elizabeth A.C. Sellers
CMAJ Jan 2005, 172 (2) 158-159; DOI: 10.1503/cmaj.1041602

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Neural tube defects
Heather Dean, Kelly Watson, Elizabeth A.C. Sellers
CMAJ Jan 2005, 172 (2) 158-159; DOI: 10.1503/cmaj.1041602
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The 5 Ps need an update: toward a comprehensive sexual history
  • Don’t ignore perimenopause
  • Hospital-at-home programs in Canada: challenges and pitfalls
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire